alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION FROM THE ACCOMPANYING 
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                           4,021
<SECURITIES>                                    15,209
<RECEIVABLES>                                    5,764
<ALLOWANCES>                                     1,128
<INVENTORY>                                      3,868
<CURRENT-ASSETS>                                32,550<F1>
<PP&E>                                          37,289<F2>
<DEPRECIATION>                                (25,795)<F3>
<TOTAL-ASSETS>                                  62,663
<CURRENT-LIABILITIES>                           13,089
<BONDS>                                          1,694<F4>
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        78,073
<OTHER-SE>                                    (30,193)<F5>
<TOTAL-LIABILITY-AND-EQUITY>                    62,663
<SALES>                                          8,052
<TOTAL-REVENUES>                                 8,271<F6>
<CGS>                                            4,789
<TOTAL-COSTS>                                    4,789
<OTHER-EXPENSES>                                 3,918
<LOSS-PROVISION>                                    30
<INTEREST-EXPENSE>                                  70
<INCOME-PRETAX>                                  (506)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (506)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (506)
<EPS-PRIMARY>                                   (0.04)
<EPS-DILUTED>                                   (0.04)
<FN>
<F1>Includes Costs and estimated earnings in excess of billings on uncompleted
contracts of $4,103 and other current assets of $713.
<F2>Includes portable simulation theaters of $8,345 and film inventory of $18,465.
<F3>Includes portable simulation theaters of $4,495 and film inventory of $14,023.
<F4>Includes the non-current portions of capital leases.
<F5>Accumulated deficit.
<F6>Includes interest income of $219.
</FN>
        

</TABLE>
Exhibit 32.2



CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief
Financial Officer of Brookstone, Inc. (the Company), does hereby certify that to the undersigneds knowledge:



| | 1) | the Companys Form 10-Q for the quarterly period ended July 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2) | the information contained in the Companys Form 10-Q for the quarterly period ended July 31, 2004 fairly presents, in all material respects, the financial condition and results
of operations of the Company.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Philip W. RoizinPhilip W. RoizinExecutive Vice President, Financeand Administration, Treasurer andSecretary and Chief Financial Officer


Dated: September 9, 2004
State of New York

Supreme Court, Appellate Division

Third Judicial Department

Decided and Entered: September 15, 2016 522117 

________________________________

In the Matter of WILLIE CLARK,

Appellant,

v MEMORANDUM AND ORDER

ANTHONY J. ANNUCCI, as Acting

Commissioner of Corrections

and Community Supervision,

Respondent.

________________________________

Calendar Date: August 8, 2016

Before: Peters, P.J., McCarthy, Garry, Clark and Mulvey, JJ.

__________

Willie Clark, Comstock, appellant pro se.

Eric T. Schneiderman, Attorney General, Albany (Owen Demuth

of counsel), for respondent.

__________

Appeal from a judgment of the Supreme Court (Hayden, J.),

entered October 5, 2015 in Chemung County, which dismissed

petitioner's application, in a proceeding pursuant to CPLR

article 78, to review a determination of respondent finding

petitioner guilty of violating certain prison disciplinary rules.

During the course of a narcotics investigation at the

correctional facility where petitioner is incarcerated, certain

telephone calls made by petitioner in May 2014 were monitored and

petitioner was heard speaking to a woman regarding a plan to

bring controlled substances, including marihuana, cocaine and

pills, into the correctional facility. The woman was arrested

after she passed these substances on to a third person who was to

transport them into the correctional facility. As a result,

petitioner was charged in a misbehavior report with conspiring to
-2- 522117 

possess controlled substances, smuggling and making third-party

telephone calls. Following a tier III disciplinary hearing, he

was found guilty of the charges. On administrative appeal, the

charge of making third-party telephone calls was dismissed and

the penalties were reduced, but the modified determination was

otherwise upheld. Petitioner commenced this CPLR article 78

proceeding challenging the modified determination. Following

service of respondent's answer, Supreme Court dismissed the

petition and petitioner now appeals. 

Petitioner challenges the determination on procedural

grounds arguing, among other things, that he was improperly

denied as a witness the unnamed third party referenced in the

misbehavior report. Significantly, the investigator who

testified at the hearing indicated that this person's identity

was confidential due to the fact that the criminal investigation

was still ongoing. Given that the revelation of this

individual's name could compromise the investigation and

jeopardize institutional security, the denial of petitioner's

request was not improper (see Matter of Williams v Goord, 23 AD3d

872, 873 [2005]; Matter of Fludd v Goord, 18 AD3d 929, 930

[2005]; see also Matter of Shannon v Goord, 282 AD2d 909, 910

[2001]). We have considered petitioner's remaining contentions

and find that they are either unpreserved for our review or are

lacking in merit. Therefore, the petition was properly

dismissed.

Peters, P.J., McCarthy, Garry, Clark and Mulvey, JJ.,

concur.

ORDERED that the judgment is affirmed, without costs.

ENTER:

Robert D. Mayberger

Clerk of the Court
SCHEDULE O 

(Form 8865)

Department of the Treasury 

Internal Revenue Service

Transfer of Property to a Foreign Partnership 

(under section 6038B)

▶ Attach to Form 8865. See Instructions for Form 8865.

OMB No. 1545-1668

2012

Name of transferor Filer’s identifying number

Name of foreign partnership EIN (if any) Reference ID number (see instructions)

Part I Transfers Reportable Under Section 6038B

Type of 

property

(a) 

Date of 

transfer

(b) 

Number of

items

transferred

(c) 

Fair market 

value on date 

of transfer

(d) 

Cost or other 

basis

(e) 

Section 704(c)

allocation

method

(f) 

Gain recognized on

transfer

(g) 

Percentage interest 

in partnership after

transfer

Cash

Stock, notes 

receivable and 

payable, and other 

securities

Inventory

Tangible 

property 

used in trade 

or business

Intangible 

property

Other 

property

Supplemental Information Required To Be Reported (see instructions):

Part II Dispositions Reportable Under Section 6038B

(a) 

Type of 

property

(b) 

Date of 

original 

transfer

(c) 

Date of

disposition

(d) 

Manner of 

disposition

(e) 

Gain 

recognized by

partnership

(f) 

Depreciation

recapture 

recognized 

by partnership

(g) 

Gain allocated 

to partner

(h) 

Depreciation 

recapture allocated to 

partner

Part III Is any transfer reported on this schedule subject to gain recognition under section 904(f)(3) or 

section 904(f)(5)(F)? . . . . . . . . . . . . . . . . . . . . . . . . . ▶ Yes No

For Paperwork Reduction Act Notice, see the Instructions for Form 8865. Cat. No. 25909U Schedule O (Form 8865) 2012
2009-1876.

#### Torrance v. Allstate Ins. Co.

In Mandamus and Prohibition. On October 26, 2009, this court found Saint Torrance to be a vexatious litigator under S.Ct.Prae.R. XIV(5)(B). This court further ordered that Torrance was prohibited from continuing or instituting legal proceedings in this court without first obtaining leave. Upon review of the documents filed in this case, the court finds the case to be without merit. Accordingly,

It is ordered by the court, sua sponte, that the case is dismissed.
Exhibit 10.7


 


	 	50
                                         Tice Boulevard





Suite A26





Woodcliff Lake, NJ 07677





(201) 645-4765 (tel)


	 	 









 


June 25, 2020


 


Zach Rome


 


Subject: Rome Employment Offer


 


Dear Zach,


 


On behalf of PaxMedica, Inc. (“PaxMedica”
or the “Company”), I am pleased to extend to you an offer of employment for the role of Chief Operating Officer.
This position will be located at PaxMedica’s current headquarters at 50 Tice Boulevard, Suite A26, Woodcliff Lake,
NJ 07677. You will report to me. Your start date will be mutually determined, but I anticipate it to be on or around July 1,
2020. I am excited about the possibility of you joining the team and your helping to build our high value neurodevelopmental biopharma
company.


 


The terms of your employment offer are outlined below:


 


		·	Part-time employment,
                                         up to 20 hours per week, as required.






		·	Initial monthly
                                         base pay of $8,333.33, which, when annualized, is equivalent to $100,000 per year.






		·	Participation
                                         (pro-rated for 2020) in a Performance Bonus Plan with a target of 50% of your base salary,
                                         based on company and individual achievement. Your bonus will be based on your performance
                                         meeting mutually established individual goals and objectives to support the growth strategy
                                         of the Company as well as the Company’s overall performance. Upon early termination
                                         of your employment without cause, the maximum accrued but unpaid bonus (through the date
                                         of termination) will be paid out promptly.






		·	Your agreement
                                         not to compete with the Company in any capacity on any product candidate or product in
                                         the field of neurodevelopment, so long as you are employed by the Company.



 


This offer of employment pursuant to the above terms shall
remain in effect for two years from your start date, with automatic one-year renewals, unless terminated sooner either by you
or the Company.


 





Confidential






     1


     


    

 


If you understand and accept these terms, please sign and return
one copy of this offer letter to me.


 


I would love to have you join the PaxMedica team and be a part
of building a great company. Should you have any questions regarding this offer, please feel free to contact me at: .


 


 





	Sincerely,	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	/s/ Howard Weisman	 	 	 	 
	Howard Weisman	 	 	 	 
	Chief Executive Officer	 	 	 	 
	PaxMedica, Inc.	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	Agreed to and Accepted
    by:	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	/s/ Zach Rome	 	 	June 25,
                                         2020	 
	Zach Rome	 	 	Date	 





 


Confidential






     2
# RTCP-Calculator Worksheet

# Sheet2

# Sheet1

# Sheet3

# Sheet4

# Sheet5

# Sheet6
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                              JAN-1-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          36,245
<SECURITIES>                                         0
<RECEIVABLES>                                   31,581
<ALLOWANCES>                                     1,411
<INVENTORY>                                     18,882
<CURRENT-ASSETS>                                86,425
<PP&E>                                         208,270
<DEPRECIATION>                                  23,595
<TOTAL-ASSETS>                                 448,764
<CURRENT-LIABILITIES>                           41,421
<BONDS>                                        325,344
<PREFERRED-MANDATORY>                            5,500
<PREFERRED>                                          0
<COMMON>                                            93
<OTHER-SE>                                      37,510
<TOTAL-LIABILITY-AND-EQUITY>                   448,764
<SALES>                                        100,033
<TOTAL-REVENUES>                               100,033
<CGS>                                           80,758
<TOTAL-COSTS>                                   80,758
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,140
<INCOME-PRETAX>                                (6,614)
<INCOME-TAX>                                   (2,100)
<INCOME-CONTINUING>                            (4,514)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                               (18,658)
<CHANGES>                                            0
<NET-INCOME>                                  (23,172)
<EPS-PRIMARY>                                   (2.49)
<EPS-DILUTED>                                   (2.49)
        

</TABLE>
EXHIBIT 32.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Oregon Steel Mills, Inc. (the
"Company") on Form 10-Q for the quarterly period ended June 30, 2004 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, James E. Declusin, President and Chief Executive Officer of the Company, and
I, L. Ray Adams, Vice President - Finance, Chief Financial Officer and Treasurer
of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our
knowledge:

(1)  The Report fully complies with the requirements of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78c(d)); and

(2)  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.



/s/ James E. Declusin
---------------------------------
James E. Declusin
President and Chief Executive Officer

September 13, 2004



---------------------------------
L. Ray Adams
Vice President - Finance,
Chief Financial Officer, and Treasurer

September 13, 2004
I

103D CONGRESS

1ST SESSION H. R. 2431

To designate the Federal building in Jacksonville, Florida, as the ‘‘Charles

E. Bennett Federal Building’’.

IN THE HOUSE OF REPRESENTATIVES

JUNE 16, 1993

Ms. BROWN of Florida (for herself, Mr. MINETA, and Mr. TRAFICANT) introduced the following bill; which was referred to the Committee on Public

Works and Transportation

A BILL

To designate the Federal building in Jacksonville, Florida,

as the ‘‘Charles E. Bennett Federal Building’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DESIGNATION.

4 The Federal building at 400 Bay Street in Jackson5 ville, Florida, is designated as the ‘‘Charles E. Bennett

6 Federal Building’’. If a new Federal building is built in

7 Jacksonville, Florida, to replace the building at 400 Bay

8 Street, the new Federal building shall be designated as

9 the ‘‘Charles E. Bennett Federal Building’’.
2

•HR 2431 IH

1 SEC. 2. LEGAL REFERENCES.

2 Any reference in any law, regulation, document,

3 record, map, or other paper of the United States to the

4 Federal building referred to in section 1 is deemed to be

5 a reference to the ‘‘Charles E. Bennett Federal Building’’.

Æ
ex_192058.htm


Exhibit 10.1


 


EIGHTH AMENDMENT


TO THE 


BIOSIG TECHNOLOGIES, INC.2012 EQUITY INCENTIVE PLAN


 


This EIGHTH AMENDMENT TO THE BIOSIG TECHNOLOGIES, INC. 2012 EQUITY INCENTIVE PLAN (this “Amendment”), effective as of June 26, 2020, is made and entered into by BioSig Technologies, Inc., a Delaware corporation (the “Company”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the BioSig Technologies, Inc. 2012 Equity Incentive Plan (the “Plan”).


 


RECITALS


 


WHEREAS, Section 18 of the Plan provides that the Board may amend the Plan at any time; and


 


WHEREAS, the Board desires to amend the Plan, to increase the number of shares of Common Stock that may be delivered pursuant to Awards under the Plan by an additional two million five hundred thousand shares (2,500,000).


 


NOW, THEREFORE, in accordance with Section 18 of the Plan, the Company hereby amends the Plan as follows:


 


1.     Section 3(a) of the Plan is hereby amended by deleting said section in its entirety and substituting in lieu thereof the following new Section 3(a):


 


(a)      Stock Subject to the Plan. Subject to the provisions of Section 13 of the Plan, the maximum aggregate number of Shares that may be subject to Awards and sold under the Plan is 11,974,450 Shares, plus (i) any Shares that, as of the date of stockholder approval of this Plan, have been reserved but not issued pursuant to any awards granted under the BioSig Technologies, Inc. 2011 Long-Term Incentive Plan (the “2011 Plan”) and are not subject to any awards granted thereunder, and (ii) any Shares subject to stock options or similar awards granted under the 2011 Plan that expire or otherwise terminate without having been exercised in full and Shares issued pursuant to awards granted under the 2011 Plan that are forfeited to or repurchased by the Company, with the maximum number of Shares to be added to the Plan pursuant to clauses (i) and (ii) equal to 1,500,000 Shares. The Shares may be authorized but unissued, or reacquired Common Stock.


 


2.      Except as expressly amended by this Amendment, the Plan shall continue in full force and effect in accordance with the provisions thereof.


 


[Remainder of Page Intentionally Left Blank;


Signature Page Follows.]


 





 










 








 


 


 


 


 


IN WITNESS WHEREOF, the Company has caused this Amendment to be duly executed as of the date first written above.


 


BIOSIG TECHNOLOGIES, INC.


 


 


 


                              By:          /s/ Kenneth L. Londoner               


                              Name:     Kenneth L. Londoner                    


                              Title:       Chairman and Chief Executive Officer
<PAGE>

                                                                    Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Superconductive Components,
Inc. (the "Company") on Form 10-QSB for the period ending June 30, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Daniel Rooney, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the requirements of section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and result of operations
            of the Company.

Date: August 1, 2005

                                      /s/ Daniel Rooney
                                      ----------------------------------------
                                      Daniel Rooney
                                      President and Chief Executive Officer of
                                      Superconductive Components, Inc.
An official website of the United States government

Here’s how you know

**Official websites use .gov** A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS** A **lock** ( Lock           A locked padlock           ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

**

Farm Service Agency

U.S. DEPARTMENT OF AGRICULTURE

                      - About FSA
                      - Ask USDA
                      - Contact Us
                      - Forms

- Home
- Programs & Services  - ARC/PLC Program
- Civil Rights
- Certified Mediation Program
- Climate Adaptation Plan
- Conservation Programs
- Cooperative Agreements
- Dairy Margin Coverage Program
- Disaster Assistance Programs
- Economic & Policy Analysis
- Emergency Relief
- Environmental & Cultural Resource Compliance 
- Farm Bill Home
- Farm Labor Stabilization & Protection Pilot Grants
- Farm Loan Programs
- Financial Management Information
- Increasing Land Access
- Initiatives
- Laws and Regulations
- Margin Protection Program for Dairy
- Market Facilitation Program
- MIDAS
- Organic Certification Cost Share Program
- Outreach & Education
- Payment Eligibility
- Price Support
- Rice Production Program

- State Offices
- Online Services  - LDP
- eARC/PLC
- Farmers.gov (FSA Farm+)
- FSA Online Data Resources
- Loan Assistance Tool

- Newsroom  - Fact Sheets
- News Releases
- Emergency Designations
- Stakeholder Information
- eFOIA
- Meetings & Events
- Public Service Announcements
- County Committee Elections
- Fence Post

# Iowa State Events

- Section Topics
- Iowa Home
- County Offices
- County PCP Data
- Daily LDP Rates
- Programs
- Newsletters
- State Events
- State News Releases
- Resources

#### State Executive Director

Matt Russell
Read Matt Russell'

####  State Office Address

515-254-1540

855-218-8672

## Calendar of Iowa Events

## Dates to Remember

**Important Upcoming Program Dates **

- Home
- Programs & Services
- State Offices
- Online Services
- Newsroom

- Farmers.gov
- USA.gov
- USDA.gov
- Whitehouse.gov

- Accessibility Statement
- Common Questions
- Freedom of Information Act

- No FEAR Report
- Information Quality
- Non-Discrimination Statement

- Policies and Links
- Privacy Policy
- Sitemap

#### Sign up for updates

**

Farm Service Agency

U.S. DEPARTMENT OF AGRICULTURE

Facebook

YouTube

Twitter

Twitter

RSS